Caladrius Biosciences Inc. | Ownership
Companies that own Caladrius Biosciences Inc.
Sanford Health Plan (Investment Portfolio)
1,059,322
10.89%
0
100%
03/22/2017
Renaissance Technologies LLC
196,563
2.02%
49,511
0%
06/30/2018
The Vanguard Group, Inc.
194,748
2%
9,408
0%
06/30/2018
BlackRock Fund Advisors
48,987
0.5%
3,209
0%
06/30/2018
Geode Capital Management LLC
46,538
0.48%
19,630
0%
06/30/2018
Dimensional Fund Advisors LP
40,503
0.42%
6,738
0%
06/30/2018
Jacobs Levy Equity Management, Inc.
34,876
0.36%
-1,506
0%
06/30/2018
Ameriprise Financial Services, Inc. (Investment Management)
17,783
0.18%
-10,689
0%
06/30/2018
Acadian Asset Management LLC
16,424
0.17%
2,920
0%
06/30/2018
Macquarie Funds Management Hong Kong Ltd.
14,743
0.15%
-25,108
0%
06/30/2018
| Address |
110 Allen Road
Basking Ridge New Jersey 07920
United States
|
|
Employees
|
- |
| Website |
http://www.caladrius.com |
| Updated |
07/08/2019 |
| Caladrius Biosciences, Inc. operates as a global healthcare company, which engages in developing cellular therapies that repair damaged tissue, cells and organs and restore their normal function. It is pursuing the preservation and enhancement of human health globally through the development of cell based therapeutics that prevent, treat or cure disease. Its business includes the development of novel proprietary cell therapy products, as well as a revenue-generating contract development and manufacturing service business that it leverages for the development of therapeutics while providing service to other companies in the cell therapy industry developing products. |
